Suppr超能文献

Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.

作者信息

Xiong Changming, Yang Beilan

机构信息

Center of Pulmonary Vascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

出版信息

J Transl Int Med. 2023 Mar 7;11(1):1-3. doi: 10.2478/jtim-2022-0023. eCollection 2023 Mar.

Abstract
摘要

相似文献

1
Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.
J Transl Int Med. 2023 Mar 7;11(1):1-3. doi: 10.2478/jtim-2022-0023. eCollection 2023 Mar.
4
Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization.
Ann Am Thorac Soc. 2022 Dec;19(12):1977-1985. doi: 10.1513/AnnalsATS.202201-077OC.
5
Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2023 Apr 4;12(7):e029085. doi: 10.1161/JAHA.122.029085. Epub 2023 Mar 28.
7
Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.
Ann Noninvasive Electrocardiol. 2020 Sep;25(5):e12758. doi: 10.1111/anec.12758. Epub 2020 Apr 26.
8
Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients.
Intern Emerg Med. 2021 Apr;16(3):625-632. doi: 10.1007/s11739-020-02467-0. Epub 2020 Aug 14.
9
[How do we respond to the newly-revised haemodynamic definitions of pulmonary hypertension].
Zhonghua Yi Xue Za Zhi. 2023 Jan 10;103(2):73-77. doi: 10.3760/cma.j.cn112137-20221021-02198.
10
ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.
Biomed Res Int. 2018 Apr 10;2018:4606053. doi: 10.1155/2018/4606053. eCollection 2018.

引用本文的文献

1
Adipokines in preeclampsia: disrupted signaling pathways and novel therapeutic strategies.
Eur J Med Res. 2025 Aug 4;30(1):702. doi: 10.1186/s40001-025-02972-y.
2
Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review).
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5599. Epub 2025 Aug 1.
3
MAM kinases: physiological roles, related diseases, and therapeutic perspectives-a systematic review.
Cell Mol Biol Lett. 2025 Mar 28;30(1):35. doi: 10.1186/s11658-025-00714-w.
6
Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation.
Adv Sci (Weinh). 2025 Feb;12(6):e2412593. doi: 10.1002/advs.202412593. Epub 2024 Dec 16.
8
2023 Guideline for the management of hypertension in the elderly population in China.
J Geriatr Cardiol. 2024 Jun 28;21(6):589-630. doi: 10.26599/1671-5411.2024.06.001.
9
The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy.
J Geriatr Cardiol. 2024 Jun 28;21(6):669-681. doi: 10.26599/1671-5411.2024.06.003.

本文引用的文献

1
Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.
J Transl Int Med. 2022 Jul 2;10(2):125-133. doi: 10.2478/jtim-2022-0027. eCollection 2022 Jun.
5
Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00197-2019. Print 2019 Mar.
6
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
7
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
Eur Respir J. 2018 Apr 4;51(4). doi: 10.1183/13993003.01197-2017. Print 2018 Apr.
8
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.
Am J Respir Crit Care Med. 2018 Feb 15;197(4):509-516. doi: 10.1164/rccm.201706-1215OC.
10
Definitions and diagnosis of pulmonary hypertension.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验